MALARIA

This study is testing whether a new drug called SJ733, when combined with an existing drug (tafenoquine), can completely cure P. vivax malaria and prevent it from coming back. It will involve about 104 adults with active malaria infection. Researchers will compare different lengt…

This trial is testing whether a much shorter, 3-day treatment can completely cure relapsing malaria. It will involve over 1,000 people aged 5 and older who have the infection. The goal is to find a safer, easier-to-complete cure that could change global treatment guidelines.

This study aims to see if giving people half the usual amount of the R21 malaria vaccine works just as well as the full dose. Researchers will compare the immune response and safety in teens and adults receiving different doses. The goal is to find the most efficient way to use t…

This study is testing whether giving a single dose of an antibody called L9LS can improve how well the body responds to a new malaria vaccine, R21/Matrix-M. It will involve 24 healthy adults and 333 healthy infants in Mali. Researchers want to see if the timing of the antibody sh…

This study will test whether new LASER Guardian devices that release mosquito-repelling chemicals can help prevent malaria in Kenyan communities. Researchers will compare these devices against standard indoor insecticide spraying and current prevention methods across 69 villages …

This study is testing if giving a malaria prevention medicine to school children every two months can reduce malaria cases for everyone in the surrounding community. It will involve about 4,800 children in areas with high malaria rates. The idea is that by protecting children, wh…

This early study aims to understand how three malaria drugs interact when taken together. Researchers will give different combinations of these drugs to 24 healthy Thai adults in a specific order, with breaks in between. The main goal is to measure drug levels in the blood and ch…